IS4147A - Aðferð til framleiðslu á 1,5 Benzodiazepine afleiðum - Google Patents

Aðferð til framleiðslu á 1,5 Benzodiazepine afleiðum

Info

Publication number: IS4147A
Authority: IS; Iceland
Prior art keywords: production; benzodiazepine derivatives; benzodiazepine; derivatives
Prior art date: 1993-04-15

Application number

IS4147A

Other languages

English (en)

Inventor

Finch Harry

Shah Pritom

Arthur Ellis Carr Robin

Original Assignee

Glaxo Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-04-15

Filing date

1994-04-11

Publication date

1994-10-16

1994-04-11 Application filed by Glaxo Inc filed Critical Glaxo Inc

1994-10-16 Publication of IS4147A publication Critical patent/IS4147A/is

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Crystallography & Structural Chemistry (AREA)
Diabetes (AREA)
Obesity (AREA)
Hematology (AREA)
Endocrinology (AREA)
Gastroenterology & Hepatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Hydrogenated Pyridines (AREA)

IS4147A 1993-04-15 1994-04-11 Aðferð til framleiðslu á 1,5 Benzodiazepine afleiðum IS4147A (is)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB939307833A GB9307833D0 (en)	1993-04-15	1993-04-15	Modulators of cholecystokinin and gastrin

Publications (1)

Publication Number	Publication Date
IS4147A true IS4147A (is)	1994-10-16

Family

ID=10733915

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
IS4147A IS4147A (is)	1993-04-15	1994-04-11	Aðferð til framleiðslu á 1,5 Benzodiazepine afleiðum
IS4148A IS4148A (is)	1993-04-15	1994-04-11	Hliðstæð aðferð til framleiðslu á 1,5 Benzodiazepine afleiðum

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
IS4148A IS4148A (is)	1993-04-15	1994-04-11	Hliðstæð aðferð til framleiðslu á 1,5 Benzodiazepine afleiðum

Country Status (33)

Country	Link
US (2)	US5646140A (is)
EP (1)	EP0694039B1 (is)
JP (1)	JP3406317B2 (is)
KR (1)	KR100364948B1 (is)
CN (1)	CN1058487C (is)
AP (2)	AP512A (is)
AT (1)	ATE198894T1 (is)
AU (1)	AU681139B2 (is)
CA (1)	CA2158973C (is)
CZ (1)	CZ286695B6 (is)
DE (1)	DE69426624T2 (is)
DK (1)	DK0694039T3 (is)
EC (1)	ECSP941066A (is)
ES (1)	ES2154674T3 (is)
FI (1)	FI954853A0 (is)
GB (1)	GB9307833D0 (is)
GR (1)	GR3035641T3 (is)
HU (1)	HU223467B1 (is)
IL (2)	IL109315A0 (is)
IS (2)	IS4147A (is)
MY (2)	MY112237A (is)
NO (1)	NO311133B1 (is)
NZ (1)	NZ265272A (is)
OA (1)	OA10355A (is)
PE (2)	PE50594A1 (is)
PH (1)	PH30897A (is)
PL (1)	PL178790B1 (is)
PT (1)	PT694039E (is)
RU (1)	RU2135486C1 (is)
SK (1)	SK281211B6 (is)
TW (1)	TW487703B (is)
WO (1)	WO1994024149A1 (is)
ZA (2)	ZA942570B (is)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2173167T3 (es) *	1993-12-28	2002-10-16	Shionogi & Co	Derivados de benzodiazepina.
SK281433B6 (sk) *	1994-04-14	2001-03-12	Glaxo Wellcome Inc.	5-heterocyklo-1,5-benzodiazepínové deriváty, spôsob ich výroby, farmaceutický prostriedok s ich obsahom a ich použitie
US5739129A (en) *	1994-04-14	1998-04-14	Glaxo Wellcome Inc.	CCK or gastrin modulating 5-heterocyclic-1, 5 benzodiazepines
EP0755394A1 (en) *	1994-04-15	1997-01-29	Glaxo Wellcome Inc.	A method of inducing cholecystokinin agonist activity using 1,4-benzodiazepine compounds
PE27497A1 (es) *	1994-04-15	1997-08-07	Glaxo Inc	Derivados de 1,5 benzodiazepina
GB9420763D0 (en) *	1994-10-14	1994-11-30	Glaxo Inc	Acetamide derivatives
US5910495A (en) *	1994-10-14	1999-06-08	Glaxo Wellcome Inc.	Use of 1,5-benzo b!1,4-diazepines to control gastric emptying
US5780464A (en) *	1994-10-14	1998-07-14	Glaxo Wellcome Inc.	Enteric coated compositions of 1,5-benzodiazepine derivatives having CCK antagonistic or agonistic activity
GB9420747D0 (en) *	1994-10-14	1994-11-30	Glaxo Inc	1,5 benzodiazepine derivatives
GB9420748D0 (en) *	1994-10-14	1994-11-30	Glaxo Inc	1,5 benzodiazepine derivatives
WO1997021731A1 (en)	1995-12-11	1997-06-19	New England Medical Center Hospitals, Inc.	Assay for and uses of peptide hormone receptor ligands
US5750353A (en) *	1995-12-11	1998-05-12	New England Medical Center Hospitals, Inc.	Assay for non-peptide agonists to peptide hormone receptors
AU721081B2 (en) *	1996-12-10	2000-06-22	Zeria Pharmaceutical Co., Ltd.	1,5-benzodiazepine derivatives
KR100510614B1 (ko)	1997-04-15	2005-08-30	씨에스아이알	식욕 억제 활성을 갖는 화합물의 제조를 위한 중간체 및이의 제조 방법
AR022044A1 (es) *	1999-05-06	2002-09-04	Glaxo Group Ltd	Derivados de 1,5-benzodiazepina
GB2396815B (en)	1999-10-27	2004-09-08	Phytopharm Plc	A composition comprising a pregnenone derivative and an NSAID
GB2363985B (en)	2000-06-30	2004-09-29	Phytopharm Plc	Extracts,compounds & pharmaceutical compositions having anti-diabetic activity and their use
US6768024B1 (en)	2000-08-04	2004-07-27	Lion Bioscience Ag	Triamine derivative melanocortin receptor ligands and methods of using same
US20020180095A1 (en) *	2001-05-29	2002-12-05	Berard Steven O.	Thermally conductive carbon fiber extrusion compounder and method of using same
US7074805B2 (en) *	2002-02-20	2006-07-11	Abbott Laboratories	Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
MXPA04008073A (es) *	2002-02-20	2004-11-26	Abbott Lab	Compuestos azabiciclicos fusionados que inhiben el receptor de subtipo 1 (vr1) del receptor de vainilloide.
US6933311B2 (en) *	2003-02-11	2005-08-23	Abbott Laboratories	Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
US7015233B2 (en)	2003-06-12	2006-03-21	Abbott Laboratories	Fused compounds that inhibit vanilloid subtype 1 (VR1) receptor
RU2261246C1 (ru) *	2004-04-15	2005-09-27	Общество с ограниченной ответственностью "Исследовательский Институт Химического Разнообразия" (ООО "Исследовательский Институт Химического Разнообразия")	Замещенные 7-сульфонил бензо[b][1,4]диазепины (варианты), способы их получения (варианты), фокусированная библиотека и фармацевтическая композиция
BRPI0510273A (pt) *	2004-05-25	2007-10-30	Pfizer Prod Inc	derivados de tetraazabenzo[e]azuleno e análogos destes
CN1333077C (zh) *	2005-04-15	2007-08-22	华南农业大学	缩胆囊素活性片段的串联表达及其应用
RU2303597C1 (ru) *	2006-05-12	2007-07-27	Иващенко Андрей Александрович	Фармацевтическая композиция, способы ее получения и применения
CN101541758A (zh) *	2006-08-25	2009-09-23	艾博特公司	抑制trpv1的吲唑衍生物及其用途
JP2010513557A (ja)	2006-12-20	2010-04-30	アボット・ラボラトリーズ	疼痛治療のためのｔｒｐｖ１バニロイド受容体アンタゴニストとしてのｎ−（５，６，７，８−テトラヒドロナフタレン−１−イル）尿素誘導体および関連化合物
EP2323989A4 (en) *	2008-03-20	2011-06-22	Abbott Lab	METHODS FOR PREPARING AGENTS FOR THE CENTRAL NERVOUS SYSTEM THAT ARE TRPV1 ANTAGONISTS
CN103102285B (zh) *	2013-01-30	2015-07-29	淮阴师范学院	对氨基苯乙腈的制备方法
RU2720237C2 (ru)	2013-11-18	2020-04-28	Форма Терапеутикс, Инк.	Композиции, содержащие бензопиперазин, в качестве ингибиторов бромодоменов вет
MX370535B (es)	2013-11-18	2019-12-17	Forma Therapeutics Inc	Compuestos de tetrahidroquinolina como inhibidores del bromodominio extra terminal y bromo (bet) y el uso de los mismos en el tratamiento de cáncer.
EP3324977B1 (en)	2015-07-22	2022-07-13	Enanta Pharmaceuticals, Inc.	Benzodiazepine derivatives as rsv inhibitors
JP6974331B2 (ja)	2016-02-05	2021-12-01	デナリセラピューティクスインコーポレイテッドDenali Therapeutics Inc.	化合物、組成物及び方法
RS63203B1 (sr)	2016-12-09	2022-06-30	Denali Therapeutics Inc	Jedinjenja korisna kao inhibitori ripk1
CN110809472B (zh)	2017-02-16	2023-05-23	英安塔制药有限公司	用于制备苯二氮䓬衍生物的方法
WO2018226801A1 (en) *	2017-06-07	2018-12-13	Enanta Pharmaceuticals, Inc.	Aryldiazepine derivatives as rsv inhibitors
US10851115B2 (en)	2017-06-30	2020-12-01	Enanta Pharmaceuticals, Inc.	Heterocyclic compounds as RSV inhibitors
WO2019006295A1 (en)	2017-06-30	2019-01-03	Enanta Pharmaceuticals, Inc.	HETEROCYCLIC COMPOUNDS AS RSV INHIBITORS
EP3687543B1 (en)	2017-09-29	2024-03-20	Enanta Pharmaceuticals, Inc.	Combinations of pharmaceutical agents as rsv inhibitors
US10647711B2 (en)	2017-11-13	2020-05-12	Enanta Pharmaceuticals, Inc.	Azepin-2-one derivatives as RSV inhibitors
WO2019199908A1 (en)	2018-04-11	2019-10-17	Enanta Pharmaceuticals, Inc.	Heterocyclic compounds as rsv inhibitors
SG11202110137VA (en)	2019-03-18	2021-10-28	Enanta Pharm Inc	Benzodiazepine derivatives as rsv inhibitors
WO2020210246A1 (en)	2019-04-09	2020-10-15	Enanta Pharmaceuticals, Inc,	Heterocyclic compounds as rsv inhibitors
US11505558B1 (en)	2019-10-04	2022-11-22	Enanta Pharmaceuticals, Inc.	Antiviral heterocyclic compounds
UY39032A (es)	2020-01-24	2021-07-30	Enanta Pharm Inc	Compuestos heterocíclicos como agentes antivirales
US11534439B2 (en)	2020-07-07	2022-12-27	Enanta Pharmaceuticals, Inc.	Dihydroquinoxaline and dihydropyridopyrazine derivatives as RSV inhibitors
WO2022086840A1 (en)	2020-10-19	2022-04-28	Enanta Pharmaceuticals, Inc.	Heterocyclic compounds as anti-viral agents
IL314082A (en)	2022-01-12	2024-09-01	Denali Therapeutics Inc	Crystal forms of (S)-5-benzyl-N-(5-methyl-4-oxo-2,3,4,5-tetrahydropyrido[3,2-b][1,4]oxazapin-3-yl)- H4- 1,2,4-triazole-3-carboxamide
AR129003A1 (es)	2022-04-07	2024-07-03	Enanta Pharm Inc	Compuestos heterocíclicos antivirales
WO2023211997A1 (en)	2022-04-27	2023-11-02	Enanta Pharmaceuticals, Inc.	Antiviral compounds

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4517195A (en) *	1984-07-02	1985-05-14	Hoechst-Roussel Pharmaceuticals Inc.	Pyrrolo[1,2-b][1,2,5]triazepines and pharmaceutical compositions thereof
FR2641280B1 (fr) *	1988-12-29	1994-01-21	Roussel Uclaf	Nouveaux derives de la 2,4-dioxo 2,3,4,5-tetrahydro 1h-1,5-benzodiazepine, leur procede de preparation et leur application comme medicaments
SU1362732A1 (ru) *	1986-04-16	1987-12-30	Ленинградский Технологический Институт Им.Ленсовета	Способ получени 2-диалкиламино-4-метил-3н-1,5-бензодиазепинов
CH673947A5 (is) *	1986-09-23	1990-04-30	Sandoz Ag
FR2659653B1 (fr) *	1990-03-13	1992-05-22	Rhone Poulenc Sante	Derives de l'uree, leur preparation et les medicaments les contenant.
US5206234A (en) *	1990-10-22	1993-04-27	Merck & Co., Inc.	Benzolactam analogs as antagonists of cck
JP2904941B2 (ja) *	1991-01-28	1999-06-14	出光興産株式会社	スチレン系重合体の精製方法
GEP20001968B (en) *	1992-01-21	2000-03-05	Glaxo Spa	Arilthio Compounds as Antibacterial and Antiviral Agents
SK281433B6 (sk) *	1994-04-14	2001-03-12	Glaxo Wellcome Inc.	5-heterocyklo-1,5-benzodiazepínové deriváty, spôsob ich výroby, farmaceutický prostriedok s ich obsahom a ich použitie

1993
- 1993-04-15 GB GB939307833A patent/GB9307833D0/en active Pending
1994
- 1994-01-04 US US08/525,659 patent/US5646140A/en not_active Expired - Lifetime
- 1994-04-11 IS IS4147A patent/IS4147A/is unknown
- 1994-04-11 IS IS4148A patent/IS4148A/is unknown
- 1994-04-12 EC EC1994001066A patent/ECSP941066A/es unknown
- 1994-04-12 MY MYPI94000880A patent/MY112237A/en unknown
- 1994-04-12 MY MYPI94000884A patent/MY131569A/en unknown
- 1994-04-13 US US08/522,363 patent/US5585376A/en not_active Expired - Fee Related
- 1994-04-13 IL IL10931594A patent/IL109315A0/xx unknown
- 1994-04-13 PE PE1994240028A patent/PE50594A1/es not_active Application Discontinuation
- 1994-04-13 AP APAP/P/1994/000635A patent/AP512A/en active
- 1994-04-13 PE PE1994240027A patent/PE50994A1/es not_active Application Discontinuation
- 1994-04-13 AP APAP/P/1994/000634A patent/AP462A/en active
- 1994-04-13 IL IL10931694A patent/IL109316A/en not_active IP Right Cessation
- 1994-04-14 CN CN94191773A patent/CN1058487C/zh not_active Expired - Fee Related
- 1994-04-14 WO PCT/EP1994/001131 patent/WO1994024149A1/en not_active Ceased
- 1994-04-14 FI FI954853A patent/FI954853A0/fi unknown
- 1994-04-14 JP JP52273494A patent/JP3406317B2/ja not_active Expired - Fee Related
- 1994-04-14 NZ NZ265272A patent/NZ265272A/en not_active IP Right Cessation
- 1994-04-14 SK SK1253-95A patent/SK281211B6/sk unknown
- 1994-04-14 ES ES94913580T patent/ES2154674T3/es not_active Expired - Lifetime
- 1994-04-14 RU RU95117974A patent/RU2135486C1/ru not_active IP Right Cessation
- 1994-04-14 CZ CZ19952675A patent/CZ286695B6/cs not_active IP Right Cessation
- 1994-04-14 PT PT94913580T patent/PT694039E/pt unknown
- 1994-04-14 EP EP94913580A patent/EP0694039B1/en not_active Expired - Lifetime
- 1994-04-14 ZA ZA942570A patent/ZA942570B/xx unknown
- 1994-04-14 KR KR1019950704491A patent/KR100364948B1/ko not_active Expired - Fee Related
- 1994-04-14 CA CA002158973A patent/CA2158973C/en not_active Expired - Fee Related
- 1994-04-14 PH PH48093A patent/PH30897A/en unknown
- 1994-04-14 ZA ZA942571A patent/ZA942571B/xx unknown
- 1994-04-14 PL PL94311084A patent/PL178790B1/pl unknown
- 1994-04-14 AT AT94913580T patent/ATE198894T1/de not_active IP Right Cessation
- 1994-04-14 HU HU9502978A patent/HU223467B1/hu not_active IP Right Cessation
- 1994-04-14 DK DK94913580T patent/DK0694039T3/da active
- 1994-04-14 AU AU65676/94A patent/AU681139B2/en not_active Ceased
- 1994-04-14 DE DE69426624T patent/DE69426624T2/de not_active Expired - Lifetime
- 1994-05-26 TW TW083104772A patent/TW487703B/zh not_active IP Right Cessation
1995
- 1995-10-12 OA OA60722A patent/OA10355A/en unknown
- 1995-10-13 NO NO19954090A patent/NO311133B1/no unknown
2001
- 2001-03-27 GR GR20010400488T patent/GR3035641T3/el not_active IP Right Cessation

Also Published As

Publication number	Publication date
EP0694039A1 (en)	1996-01-31
ATE198894T1 (de)	2001-02-15
IL109316A0 (en)	1994-07-31
HK1003943A1 (en)	1998-11-13
PE50994A1 (es)	1995-01-06
WO1994024149A1 (en)	1994-10-27
DE69426624D1 (de)	2001-03-01
NO954090D0 (no)	1995-10-13
NO954090L (no)	1995-12-13
OA10355A (en)	2001-10-19
SK125395A3 (en)	1996-06-05
EP0694039B1 (en)	2001-01-24
MY112237A (en)	2001-05-31
AU681139B2 (en)	1997-08-21
AP512A (en)	1996-07-29
ECSP941066A (es)	1994-11-16
SK281211B6 (sk)	2001-01-18
FI954853A7 (fi)	1995-10-12
PE50594A1 (es)	1995-01-06
NO311133B1 (no)	2001-10-15
ZA942570B (en)	1994-11-11
TW487703B (en)	2002-05-21
ES2154674T3 (es)	2001-04-16
IL109316A (en)	1999-03-12
KR100364948B1 (ko)	2003-03-29
AP9400635A0 (en)	1994-04-30
MY131569A (en)	2007-08-30
CA2158973A1 (en)	1994-10-27
DK0694039T3 (da)	2001-05-21
US5646140A (en)	1997-07-08
GR3035641T3 (en)	2001-06-29
JPH08508744A (ja)	1996-09-17
CZ267595A3 (en)	1996-04-17
PL178790B1 (pl)	2000-06-30
IL109315A0 (en)	1994-07-31
CN1120843A (zh)	1996-04-17
CZ286695B6 (en)	2000-06-14
DE69426624T2 (de)	2001-06-21
FI954853L (fi)	1995-10-12
CA2158973C (en)	2006-06-06
NZ265272A (en)	1997-07-27
HUT74102A (en)	1996-11-28
GB9307833D0 (en)	1993-06-02
PH30897A (en)	1997-12-23
US5585376A (en)	1996-12-17
FI954853A0 (fi)	1995-10-12
CN1058487C (zh)	2000-11-15
PL311084A1 (en)	1996-02-05
RU2135486C1 (ru)	1999-08-27
JP3406317B2 (ja)	2003-05-12
AU6567694A (en)	1994-11-08
AP462A (en)	1996-02-19
PT694039E (pt)	2001-06-29
AP9400634A0 (en)	1994-04-30
HU223467B1 (hu)	2004-07-28
HU9502978D0 (en)	1995-12-28
ZA942571B (en)	1994-11-11
IS4148A (is)	1994-10-16

Publication	Publication Date	Title
IS4147A (is)	1994-10-16	Aðferð til framleiðslu á 1,5 Benzodiazepine afleiðum
IS4201A (is)	1995-03-01	Aðferð til framleiðslu á Benzofuran afleiðum
IS3970A (is)	1993-07-22	Hliðstæð aðferð til framleiðslu á 1,5-benzódíazepín afleiðum
IS4121A (is)	1994-07-21	Hliðstæð aðferð til framleiðslu á 2,6-Díamínópúrín afleiðum
IS3915A (is)	1993-03-19	Aðferð til framleiðslu á benzanilíð afleiðum
IS3914A (is)	1993-03-19	Aðferð til framleiðslu á benzanilíð afleiðum
MX9206450A (es)	1993-05-01	Proceso para la produccion de isoleucina-l.
NO992860D0 (no)	1999-06-11	FremgangsmÕte for fremstilling av hydrokarboner
IS3994A (is)	1993-10-17	Hliðstæð aðferð til framleiðslu á indole afleiðum
NO981800L (no)	1998-06-11	FremgangsmÕte for fremstilling av 1,1,1,3,3-pentafluorpentan
HUP9901285A3 (en)	2000-02-28	Process for the production of difluoromethane
IS3827A (is)	1992-09-28	Hliðstæð aðferð við framleiðslu á pýrról[2,3 b]pýridínum
IS5209A (is)	2000-04-13	Aðferð til framleiðslu á pýrazóló[4,3-d]pýrimidín-7-ónum og milliefnum af því
IS4190A (is)	1995-01-21	Hliðstæð aðferð til framleiðslu á 1,5 bensódíasepín afleiðum
GR3032600T3 (en)	2000-05-31	Process for the production of imidazo-benzodiazepine derivatives
HUP9904096A3 (en)	2001-02-28	Process for the production of substituted phenylpyridines
ZA985918B (en)	2000-01-10	Process for the production of indole derivatives.
FR2686898B1 (fr)	1996-09-20	Methode de production de la l-phenylalanine.
NO985535D0 (no)	1998-11-27	FremgangsmÕte for fremstilling av 1,3-alkandioler
FI960332A0 (fi)	1996-01-24	Menetelmä substituoitujan 4,6-diamino-5-syanopyrinidiinien valmistamiseksi
NO179101C (no)	1996-08-07	Fremgangsmåte for fremstilling av dibeskyttet 2,3-hydroksymetyl-cyklobutanol
IS2201B (is)	2007-02-15	Aðferð til framleiðslu á handhverfu auðguðum N-afleiddum laktömum
IS4707A (is)	1998-03-31	Aðferð til framleiðslu á díoxóazabísýklóhexönum
ZA924595B (en)	1993-12-23	Process for the production of 1-(n)-acetyl-3,5,7-trinitrocyclotetramethylenetetramine
HU913228D0 (en)	1992-01-28	Process for the production of 5-aroil-2,3-dihydro-1h-pyrrholyzine-1,1-dicarboxylates